174 related articles for article (PubMed ID: 33750899)
21. Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.
Yu H; Lou H; Zou T; Wang X; Jiang S; Huang Z; Du Y; Jiang C; Ma L; Zhu J; He W; Rui Q; Zhou J; Wen Z
Eur Radiol; 2017 Nov; 27(11):4516-4524. PubMed ID: 28534162
[TBL] [Abstract][Full Text] [Related]
22. Combining amide proton transfer-weighted and arterial spin labeling imaging to differentiate solitary brain metastases from glioblastomas.
Chen L; Li T; Li Y; Zhang J; Li S; Zhu L; Qin J; Tang L; Zeng Z
Magn Reson Imaging; 2023 Oct; 102():96-102. PubMed ID: 37172748
[TBL] [Abstract][Full Text] [Related]
23. Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy.
Jiang S; Eberhart CG; Lim M; Heo HY; Zhang Y; Blair L; Wen Z; Holdhoff M; Lin D; Huang P; Qin H; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
Clin Cancer Res; 2019 Jan; 25(2):552-561. PubMed ID: 30366937
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Value of Fractal Analysis for the Differentiation of Brain Tumors Using 3-Tesla Magnetic Resonance Susceptibility-Weighted Imaging.
Di Ieva A; Le Reste PJ; Carsin-Nicol B; Ferre JC; Cusimano MD
Neurosurgery; 2016 Dec; 79(6):839-846. PubMed ID: 27332779
[TBL] [Abstract][Full Text] [Related]
25. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
[TBL] [Abstract][Full Text] [Related]
26. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
[TBL] [Abstract][Full Text] [Related]
27. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D
J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822
[TBL] [Abstract][Full Text] [Related]
28. Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status.
Park CJ; Choi YS; Park YW; Ahn SS; Kang SG; Chang JH; Kim SH; Lee SK
Neuroradiology; 2020 Mar; 62(3):319-326. PubMed ID: 31820065
[TBL] [Abstract][Full Text] [Related]
29. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672
[TBL] [Abstract][Full Text] [Related]
30. Addition of Amide Proton Transfer Imaging to FDG-PET/CT Improves Diagnostic Accuracy in Glioma Grading: A Preliminary Study Using the Continuous Net Reclassification Analysis.
Sakata A; Okada T; Yamamoto Y; Fushimi Y; Dodo T; Arakawa Y; Mineharu Y; Schmitt B; Miyamoto S; Togashi K
AJNR Am J Neuroradiol; 2018 Feb; 39(2):265-272. PubMed ID: 29301781
[TBL] [Abstract][Full Text] [Related]
31. Amide proton transfer-weighted imaging of pediatric brainstem glioma and its predicted value for H3 K27 alteration.
Cheng D; Zhuo Z; Zhang P; Qu L; Duan Y; Xu X; Xie C; Liu X; Haller S; Barkhof F; Zhang L; Liu Y
Acta Radiol; 2023 Nov; 64(11):2922-2930. PubMed ID: 37722801
[TBL] [Abstract][Full Text] [Related]
32. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
Su C; Liu C; Zhao L; Jiang J; Zhang J; Li S; Zhu W; Wang J
AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
[TBL] [Abstract][Full Text] [Related]
33. Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics.
Carré A; Klausner G; Edjlali M; Lerousseau M; Briend-Diop J; Sun R; Ammari S; Reuzé S; Alvarez Andres E; Estienne T; Niyoteka S; Battistella E; Vakalopoulou M; Dhermain F; Paragios N; Deutsch E; Oppenheim C; Pallud J; Robert C
Sci Rep; 2020 Jul; 10(1):12340. PubMed ID: 32704007
[TBL] [Abstract][Full Text] [Related]
34. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
36. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
37. Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.
Ma B; Blakeley JO; Hong X; Zhang H; Jiang S; Blair L; Zhang Y; Heo HY; Zhang M; van Zijl PC; Zhou J
J Magn Reson Imaging; 2016 Aug; 44(2):456-62. PubMed ID: 26788865
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging.
Ding Y; Xing Z; Liu B; Lin X; Cao D
Brain Behav; 2014; 4(6):841-9. PubMed ID: 25365807
[TBL] [Abstract][Full Text] [Related]
39. Differentiation between glioblastoma, brain metastasis and subtypes using radiomics analysis.
Artzi M; Bressler I; Ben Bashat D
J Magn Reson Imaging; 2019 Aug; 50(2):519-528. PubMed ID: 30635952
[TBL] [Abstract][Full Text] [Related]
40. Radiogenomics of lower-grade gliomas: machine learning-based MRI texture analysis for predicting 1p/19q codeletion status.
Kocak B; Durmaz ES; Ates E; Sel I; Turgut Gunes S; Kaya OK; Zeynalova A; Kilickesmez O
Eur Radiol; 2020 Feb; 30(2):877-886. PubMed ID: 31691122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
